CN1039194C - 二甲胺四环素脉冲式一日一次释放系统 - Google Patents

二甲胺四环素脉冲式一日一次释放系统 Download PDF

Info

Publication number
CN1039194C
CN1039194C CN93101947A CN93101947A CN1039194C CN 1039194 C CN1039194 C CN 1039194C CN 93101947 A CN93101947 A CN 93101947A CN 93101947 A CN93101947 A CN 93101947A CN 1039194 C CN1039194 C CN 1039194C
Authority
CN
China
Prior art keywords
granule
coating
weight portions
soon
cellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN93101947A
Other languages
English (en)
Chinese (zh)
Other versions
CN1078889A (zh
Inventor
尼丁V·谢斯
小约瑟夫J·瓦洛罗斯
基思A·埃尔威
马修雷Ｇ·加内森
凯伦Ｇ·穆尼
杰里B·约翰逊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of CN1078889A publication Critical patent/CN1078889A/zh
Application granted granted Critical
Publication of CN1039194C publication Critical patent/CN1039194C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Magnetic Treatment Devices (AREA)
  • Laser Surgery Devices (AREA)
  • Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Position Fixing By Use Of Radio Waves (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN93101947A 1992-03-02 1993-02-25 二甲胺四环素脉冲式一日一次释放系统 Expired - Lifetime CN1039194C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/844,109 1992-03-02
US07/844,109 US5262173A (en) 1992-03-02 1992-03-02 Pulsatile once-a-day delivery systems for minocycline
US07/844,019 1992-03-02

Publications (2)

Publication Number Publication Date
CN1078889A CN1078889A (zh) 1993-12-01
CN1039194C true CN1039194C (zh) 1998-07-22

Family

ID=25291839

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93101947A Expired - Lifetime CN1039194C (zh) 1992-03-02 1993-02-25 二甲胺四环素脉冲式一日一次释放系统

Country Status (24)

Country Link
US (2) US5262173A (https=)
EP (1) EP0558913B1 (https=)
JP (1) JPH069407A (https=)
KR (1) KR100270491B1 (https=)
CN (1) CN1039194C (https=)
AT (1) ATE181504T1 (https=)
AU (1) AU656841B2 (https=)
CA (1) CA2090561C (https=)
CZ (1) CZ283684B6 (https=)
DE (1) DE69325402T2 (https=)
DK (1) DK0558913T3 (https=)
ES (1) ES2134221T3 (https=)
FI (1) FI110163B (https=)
GR (1) GR3031028T3 (https=)
HU (1) HU219580B (https=)
IL (1) IL104865A (https=)
LV (1) LV12399B (https=)
MX (1) MX9300998A (https=)
NO (1) NO307170B1 (https=)
NZ (1) NZ245951A (https=)
PL (1) PL171609B1 (https=)
SG (1) SG47785A1 (https=)
TW (1) TW299235B (https=)
ZA (1) ZA931444B (https=)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4031881C2 (de) * 1990-10-08 1994-02-24 Sanol Arznei Schwarz Gmbh Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung
WO1996010996A1 (en) * 1993-07-21 1996-04-18 The University Of Kentucky Research Foundation A multicompartment hard capsule with control release properties
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
GB9518465D0 (en) * 1995-09-09 1995-11-08 Smithkline Beecham Seiyaku Kk Pharmaceuticals
ZA974359B (en) * 1996-05-23 1998-05-12 Zeneca Ltd Microencapsulated compositions.
US5932437A (en) * 1998-04-13 1999-08-03 Genesis Laboratories, Inc. Control of lyme disease spirochete
BR9914251A (pt) 1998-10-01 2001-06-19 Novartis Ag Formulações orais de liberação sustentada
JP2000119181A (ja) 1998-10-06 2000-04-25 Kureha Chem Ind Co Ltd エスクレチン及びその誘導体の放出制御経口製剤
US20060240105A1 (en) * 1998-11-02 2006-10-26 Elan Corporation, Plc Multiparticulate modified release composition
EP1126826B3 (en) * 1998-11-02 2019-05-15 Alkermes Pharma Ireland Limited Multiparticulate modified release composition of methylphenidate
US20090149479A1 (en) * 1998-11-02 2009-06-11 Elan Pharma International Limited Dosing regimen
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US20050137181A1 (en) * 1999-03-17 2005-06-23 Bonner Ernest L. Method for treatment of reactive arthritis or bursitis
US7884090B2 (en) * 1999-03-17 2011-02-08 Ernest L. Bonner, Jr. Compositions and methods for the treatment of arthritis
US7691831B2 (en) * 1999-03-17 2010-04-06 Ernest L. Bonner, Jr. Pharmaceutical combination and method for treatment of reactive arthritis or bursitis
US6765000B2 (en) * 1999-03-17 2004-07-20 Bonner Jr Ernest L Treatment for reactive arthritis or bursitis
EP1165054A4 (en) * 1999-04-06 2005-02-09 Pharmaquest Ltd PHARMACEUTICAL DOSAGE FORM FOR INTERMITTENT DELIVERY OF METHYLPHENIDATE
US20030170181A1 (en) * 1999-04-06 2003-09-11 Midha Kamal K. Method for preventing abuse of methylphenidate
AU764453B2 (en) 1999-10-29 2003-08-21 Euro-Celtique S.A. Controlled release hydrocodone formulations
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
JP2003527335A (ja) * 1999-10-29 2003-09-16 エフ エム シー コーポレーション 食用コーティング組成物
MXPA03003895A (es) 2000-10-30 2003-07-28 Euro Celtique Sa Formulaciones de hidrocodona de liberacion controlada.
IL155959A0 (en) 2000-11-28 2003-12-23 Fmc Corp Edible pga (propylene glycol alginate) coating composition
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
EP2311440A1 (en) * 2001-04-05 2011-04-20 Collagenex Pharmaceuticals, Inc. Controlled delivery of tetracycline compounds and tetracycline derivatives
WO2002100381A1 (en) * 2001-06-07 2002-12-19 Tanabe Seiyaku Co., Ltd. Functional grain-containing preparations quickly disintegrated in the oral cavity
US6958161B2 (en) 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
ES2291749T5 (es) 2002-12-20 2011-07-21 F. Hoffmann-La Roche Ag Formulación de altas dosis de ibandronato.
WO2004091483A2 (en) * 2003-04-07 2004-10-28 Shire Laboratories, Inc. Once daily formulations of tetracyclines
GB2414668B (en) * 2004-06-03 2009-07-29 Dexcel Ltd Tetracycline modified release delivery system
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
US20060121112A1 (en) * 2004-12-08 2006-06-08 Elan Corporation, Plc Topiramate pharmaceutical composition
AU2006235483B2 (en) * 2005-04-12 2010-11-25 Elan Pharma International Limited Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080318910A1 (en) * 2005-10-04 2008-12-25 Mistral Pharma, Inc. Controlled-Release Oral Dosage Form
US20070166273A1 (en) * 2006-01-19 2007-07-19 Krivulka Joseph J Skin treatment educational kit
PT103661B (pt) * 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina
JP2010521494A (ja) * 2007-03-16 2010-06-24 エラン・ファルマ・インターナショナル・リミテッド 麻薬性および非麻薬性鎮痛剤の組み合わせ
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
SG185296A1 (en) 2007-10-12 2012-11-29 Takeda Pharmaceuticals Usa Inc Methods of treating gastrointestinal disorders independent of the intake of food
WO2010017310A1 (en) 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
EP2699236B1 (en) * 2011-04-22 2018-06-20 Napo Pharmaceuticals Inc Pharmacologically optimized multimodal drug delivery system for nordihydroguiaretic acid (ndga)
PT2704698T (pt) 2011-05-05 2019-11-19 Hennig Arzneimittel Gmbh&Co Kg Forma farmacêutica para a libertação controlada de princípios activos
DE102011075354A1 (de) * 2011-05-05 2012-11-08 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur gezielten Freigabe von Wirkstoffen
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
US11103517B2 (en) 2015-04-07 2021-08-31 Dr. Reddy's Laboratories Ltd. Pharmaceutical compositions for minocycline
CN108414466A (zh) * 2018-03-09 2018-08-17 浙江美华鼎昌医药科技有限公司 一种盐酸米诺环素缓释片体外溶出测定方法
EP3810114A4 (en) * 2018-04-30 2022-01-19 Melinta Therapeutics, Inc. METHODS OF TREATING BACTERIAL INFECTIONS USING ORITAVANCIN

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4250166A (en) * 1977-05-27 1981-02-10 Shionogi & Co., Ltd. Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL270408A (https=) * 1960-10-20
US3865935A (en) * 1972-08-10 1975-02-11 Abbott Lab Tableting of erythromycin base
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
FR2447192A1 (fr) * 1979-01-25 1980-08-22 Adria Lab Inc Forme galenique a liberation prolongee d'indoprofene
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
JPS61210025A (ja) * 1985-03-14 1986-09-18 Teisan Seiyaku Kk 安定化された抗生物質複合顆粒製剤
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
EP0327295A3 (en) * 1988-02-01 1989-09-06 F.H. FAULDING & CO. LTD. Tetracycline dosage form
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
ATE114472T1 (de) * 1989-09-21 1994-12-15 American Cyanamid Co System des typs ''einmal täglich'' zur gepulsten minocyclinabgabe.
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
US5286497A (en) * 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4250166A (en) * 1977-05-27 1981-02-10 Shionogi & Co., Ltd. Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds

Also Published As

Publication number Publication date
JPH069407A (ja) 1994-01-18
SG47785A1 (en) 1998-04-17
DE69325402D1 (de) 1999-07-29
KR100270491B1 (ko) 2000-11-01
IL104865A (en) 1997-02-18
PL171609B1 (pl) 1997-05-30
LV12399A (lv) 1999-12-20
PL297903A1 (en) 1993-11-15
EP0558913A1 (en) 1993-09-08
US5262173A (en) 1993-11-16
HUT64851A (en) 1994-03-28
DE69325402T2 (de) 2000-02-17
NO307170B1 (no) 2000-02-21
DK0558913T3 (da) 1999-12-13
CN1078889A (zh) 1993-12-01
NZ245951A (en) 1994-06-27
ATE181504T1 (de) 1999-07-15
NO930743L (no) 1993-09-03
MX9300998A (es) 1993-09-01
KR930019209A (ko) 1993-10-18
CZ30093A3 (en) 1994-02-16
GR3031028T3 (en) 1999-12-31
HU219580B (hu) 2001-05-28
CA2090561A1 (en) 1993-09-03
ES2134221T3 (es) 1999-10-01
NO930743D0 (no) 1993-03-01
IL104865A0 (en) 1993-06-10
CZ283684B6 (cs) 1998-06-17
FI930906A0 (fi) 1993-03-01
AU3384293A (en) 1993-09-09
CA2090561C (en) 2004-10-05
ZA931444B (en) 1993-10-14
HU9300570D0 (en) 1993-05-28
AU656841B2 (en) 1995-02-16
FI110163B (fi) 2002-12-13
LV12399B (en) 2000-06-20
US5348748A (en) 1994-09-20
HK1009930A1 (en) 1999-06-11
TW299235B (https=) 1997-03-01
FI930906L (fi) 1993-09-03
EP0558913B1 (en) 1999-06-23

Similar Documents

Publication Publication Date Title
CN1039194C (zh) 二甲胺四环素脉冲式一日一次释放系统
CN1035039C (zh) 二甲胺四环素药物传递系统的制备方法
CN100341493C (zh) 用于延时和受控释放药物活性成分的微粒口服盖仑制剂
CN1023293C (zh) 一种含有美多心安盐的控制释放制剂的制备方法
CN1976682A (zh) 用于延时和控制释放药物活性成分的微粒口服盖仑制剂
CN103442727B (zh) 多微粒l-薄荷醇制剂及相关方法
CN1023191C (zh) 生产持续释放异丁丙苯酸制剂的方法
JP2000515871A (ja) トラマドール複式ユニット製剤
CN1080169A (zh) 含有水溶性药物的控释片
CN87107792A (zh) 包衣膜及由它制备的组合物
RS77904A (sr) Oblik za oralnu primenu teško rastvornih baznih delotvornih supstanci
CN1886119A (zh) 泮托拉唑多颗粒制剂
CN1187052C (zh) 含有司他夫定(stavudine)的持续释放微球
CN1863518A (zh) 含有非诺贝特的药物组合物及其制备方法
CN1155369C (zh) 含有5-asa的控释口服药物组合物及其治疗肠道疾病的方法
JP2005521682A (ja) 結腸放出組成物
CN1589156A (zh) 含有对酸不稳定的生理活性化合物的制剂组合物及其制法
WO2013144176A1 (en) Controlled release formulatin comprising mesalamine
HU229569B1 (hu) Szelektív szerotoninújrafelvétel-gátlók szabályozott kibocsátású többrészecskés kiszerelései
CN1285738A (zh) 卡维地洛的新的口服剂型
CN102933204A (zh) 涂覆粒子及涂覆粒子的制造方法
RU2205006C2 (ru) Фармацевтические композиции
CN101596162B (zh) 盐酸多西环素肠溶微丸
JP2019508441A (ja) システアミンまたはその塩を含む持効性放出医薬組成物
RU2727721C2 (ru) Фармацевтическая композиция с замедленным высвобождением, содержащая ривастигмин

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: WYETH(AMERICAN HOME PRODUCTS) HOLDING CO., LTD.

Free format text: FORMER NAME OR ADDRESS: AMERICAN CYANAMID COMPANY

CP01 Change in the name or title of a patent holder

Patentee after: Wyeth Holding Corp.

Patentee before: American Cyanamid Co.

C17 Cessation of patent right
CX01 Expiry of patent term

Expiration termination date: 20130225

Granted publication date: 19980722